Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination

Journal of Nutritional Biochemistry

Volumn 26, Issue 4, 2015, Pages 378-390

  Carvalho, Fabiano B ^a   Gutierres, Jessié M ^a   Bohnert, Crystiani ^a   Zago, Adriana M ^a   Abdalla, Fátima H ^a   Vieira, Juliano M ^a   Palma, Heloisa E ^a   Oliveira, Sara M ^a   Spanevello, Roselia M ^b   Duarte, Marta M ^a   Lopes, Sonia T A ^a   Aiello, Graciane ^a   Amaral, Marta G ^b   Pippi, Ney Luis ^a   Andrade, Cinthia M ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Anthocyanins; ATPases; Ethidium bromide; Multiple sclerosis; Neuroinflammation; Oxidative stress

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 4 HYDROXYNONENAL; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTHOCYANIN; CARBONYL DERIVATIVE; ETHIDIUM BROMIDE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MALONALDEHYDE; NITROGEN DIOXIDE; QUERCETIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; 4-HYDROXY-2-NONENAL; ALDEHYDE; ANTIOXIDANT; ETHIDIUM; INTERLEUKIN 6; ION TRANSPORT; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DEMYELINATION; DOSE RESPONSE; EC50; ENZYMATIC ASSAY; ENZYME ACTIVITY; IN VITRO STUDY; INFLAMMATORY INFILTRATE; ION TRANSPORT; MALE; MEDIATOR RELEASE; MYELIN SHEATH; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PONS; PROTEIN CONTENT; RAT; SYNAPTIC TRANSMISSION; ANIMAL; DEMYELINATING DISEASES; DRUG EFFECTS; INFLAMMATION; LIPID PEROXIDATION; METABOLISM; WISTAR RAT;

ANIMALIA; RATTUS;

ALDEHYDES; ANIMALS; ANTHOCYANINS; ANTIOXIDANTS; CALCIUM-TRANSPORTING ATPASES; DEMYELINATING DISEASES; ETHIDIUM; GLUTATHIONE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; ION PUMPS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MYELIN SHEATH; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SODIUM-POTASSIUM-EXCHANGING ATPASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925326464     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.11.006     Document Type: Article

References (120)

1. Stadelmann C., Wegner C., Bruck W. Inflammation, demyelination, and degeneration - recent insights from MS pathology. Biochim Biophys Acta 1812, 2011:275-282.
2. Kipp M., van der Valk P., Amor S. Pathology of multiple sclerosis. CNS Neurol Disord Drug Targets 2012, 11:506-517.
3. Maillart E., Papeix C. Treatment of multiple sclerosis: new approaches to treat case by case. Rev Prat 2013, 63:647-650.
4. Stys P.K. Pathoetiology of multiple sclerosis: are we barking up the wrong tree? F1000 prime reports 2013, 5:20.
5. Mehanna R., Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci 2013, 328:1-8.
6. Irvine K.A., Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008, 131:1464-1477.
7. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998, 280:1610-1613.
8. Skou J.C. Enzymatic basis for active transport of Na+ and K+ across cell membrane. Physiol Rev 1965, 45:596-617.
9. Skou J.C. The (Na+ + K+)-ATPase: coupling of the reaction with ATP to the reaction with Na+and K+. Ann N Y Acad Sci 1982, 402:169-184.
10. Kaplan J.H. Biochemistry of Na,K-ATPase. Annu Rev Biochem 2002, 71:511-535.
11. Jorgensen P.L., Hakansson K.O., Karlish S.J. Structure and mechanism of Na, K-ATPase: functional sites and their interactions. Annu Rev Physiol 2003, 65:817-849.
12. Aperia A. New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target. J Intern Med 2007, 261:44-52.
13. Fakira A.K., Elkabes S. Role of plasma membrane calcium ATPase 2 in spinal cord pathology. World J Biol Chem 2010, 1:103-108.
14. Tachibana T., Ogura H., Tokunaga A., Dai Y., Yamanaka H., Seino D., et al. Plasma membrane calcium ATPase expression in the rat spinal cord. Brain Res Mol Brain Res 2004, 131:26-32.
15. Young E.A., Fowler C.D., Kidd G.J., Chang A., Rudick R., Fisher E., et al. Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions. Ann Neurol 2008, 63:428-435.
16. Garay L., Gonzalez Deniselle M.C., Gierman L., Meyer M., Lima A., Roig P., et al. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 2008, 15:76-83.
17. Kurnellas M.P., Nicot A., Shull G.E., Elkabes S. Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury. FASEB J 2005, 19:298-300.
18. Essa M.M., Vijayan R.K., Castellano-Gonzalez G., Memon M.A., Braidy N., Guillemin G.J. Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res 2012, 37:1829-1842.
19. Otaegui-Arrazola A., Amiano P., Elbusto A., Urdaneta E., Martinez-Lage P. Diet, cognition, and Alzheimer's disease: food for thought. Eur J Nutr 2014, 53(1):1-23. 10.1007/s00394-013-0561-3.
20. Pratico D. Antioxidants for Alzheimer disease. JAMA Neurol 2013, 70(2):270.
21. Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P.L. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol 2013, 698:6-18.
22. Tasset I., Aguera E., Sanchez-Lopez F., Feijoo M., Giraldo A.I., Cruz A.H., et al. Peripheral oxidative stress in relapsing-remitting multiple sclerosis. Clin Biochem 2012, 45:440-444.
23. Acar A., Ugur Cevik M., Evliyaoglu O., Uzar E., Tamam Y., Arikanoglu A., et al. Evaluation of serum oxidant/antioxidant balance in multiple sclerosis. Acta Neurol Belg 2012, 112:275-280.
24. Welch C.R., Wu Q., Simon J.E. Recent advances in anthocyanin analysis and characterization. Curr Anal Chem 2008, 4:75-101.
25. Williams C.A., Grayer R.J. Anthocyanins and other flavonoids. Nat Prod Rep 2004, 21:539-573.
26. Williamson G., Clifford M.N. Colonic metabolites of berry polyphenols: the missing link to biological activity?. Br J Nutr 2010, 104(Suppl. 3):S48-S66.
27. Kahkonen M.P., Hopia A.I., Heinonen M. Berry phenolics and their antioxidant activity. J Agric Food Chem 2001, 49:4076-4082.
28. Kahkonen M.P., Heinonen M. Antioxidant activity of anthocyanins and their aglycons. J Agric Food Chem 2003, 51:628-633.
29. Gutierres J.M., Carvalho F.B., Schetinger M.R., Rodrigues M.V., Schmatz R., Pimentel V.C., et al. Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats. Life Sci 2012, 91:1221-1228.
30. Mossalayi M.D., Rambert J., Renouf E., Micouleau M., Merillon J.M. Grape polyphenols and propolis mixture inhibits inflammatory mediator release from human leukocytes and reduces clinical scores in experimental arthritis. Phytomedicine 2013, 21(3):290-297.
31. Serra D., Paixao J., Nunes C., Dinis T.C., Almeida L.M. Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic Acid. PLoS One 2013, 6,8(9):e73001.
32. Riso P., Klimis-Zacas D., Del Bo C., Martini D., Campolo J., Vendrame S., et al. Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur J Nutr 2013, 52:949-961.
33. Stettner M., Wolffram K., Mausberg A.K., Albrecht P., Derksen A., Methner A., et al. Promoting myelination in an in vitro mouse model of the peripheral nerve system: the effect of wine ingredients. PLoS One 2013, 7,8(6):e66079.
34. Mazzanti C.M., Spanevello R., Ahmed M., Pereira L.B., Goncalves J.F., Correa M., et al. Pre-treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents. Int J Dev Neurosci 2009, 27:73-80.
35. Mazzanti C.M., Spanevello R.M., Morsch A., Zanin R., Battisti V., Ahmed M., et al. Previous treatment with ebselen and vitamin E alters adenine nucleotide hydrolysis in platelets from adult rats experimentally demyelinated with ethidium bromide. Life Sci 2007, 81:241-248.
36. Spanevello R., Mazzanti C.M., Schmatz R., Bagatini M., Stefanello N., Correa M., et al. Effect of vitamin E on ectonucleotidase activities in synaptosomes and platelets and parameters of oxidative stress in rats experimentally demyelinated. Brain Res Bull 2009, 80:45-51.
37. Beckmann D.V., Carvalho F.B., Mazzanti C.M., Dos Santos R.P., Andrades A.O., Aiello G., et al. Neuroprotective role of quercetin in locomotor activities and cholinergic neurotransmission in rats experimentally demyelinated with ethidium bromide. Life Sci 2014, 103(2):79-87.
38. Choi H.S., Song H.S., Ukeda H., Sawamura M. Radical-scavenging activities of citrus essential oils and their components: detection using 1,1-diphenyl-2-picrylhydrazyl. J Agric Food Chem 2000, 48:4156-4161.
39. Bondan E.F., Lallo M.A., Dagli M.L., Pereira L.A., Graca D.L. Blood-brain barrier breakdown following gliotoxic drug injection in the brainstem of Wistar rats. Arq Neuropsiquiatr 2002, 60:582-589.
40. Bondan E.F., Lallo M.A., Orsini H., Bentubo H.L., Yazbek A., Macrini D.J., et al. Evaluation of locomotor activity after a local induction of toxic demyelination in the brainstem of Wistar rats. Arq Neuropsiquiatr 2006, 64:496-503.
41. Bondan E.F., Lallo M.A., Sinhorini I.L., Pereira L.A., Graca D.L. The effect of cyclophosphamide on brainstem remyelination following local ethidium bromide injection in Wistar rats. J Submicrosc Cytol Pathol 2000, 32:603-612.
42. Rendell P.G., Henry J.D., Phillips L.H., de la Piedad Garcia X., Booth P., Phillips P., et al. Prospective memory, emotional valence, and multiple sclerosis. J Clin Exp Neuropsychol 2012, 34(7):738-749.
43. Mazzanti C.M., Spanevello R.M., Pereira L.B., Goncalves J.F., Kaizer R., Correa M., et al. Acetylcholinesterase activity in rats experimentally demyelinated with ethidium bromide and treated with interferon beta. Neurochem Res 2006, 31:1027-1034.
44. Bondan E.F., Lallo M.A., Martins Mde F., Graca D.L. Schwann cell expression of an oligodendrocyte-like remyelinating pattern after ethidium bromide injection in the rat spinal cord. Arq Neuropsiquiatr 2010, 68:783-787.
45. Bondan E.F., Lallo M.A., Dagli M.L., Sanchez M., Graca D.L. Investigation into the astrocytic immunoreactivity to GFAP and vimentin in the brainstem of Wistar rats submitted to the ethidium bromide gliotoxic model. Arq Neuropsiquiatr 2003, 61:642-649.
46. Graca D.L., Bondan E.F., Pereira L.A., Fernandes C.G., Maiorka P.C. Behaviour of oligodendrocytes and Schwann cells in an experimental model of toxic demyelination of the central nervous system. Arq Neuropsiquiatr 2001, 59:358-361.
47. Skender-Gazibara M., Cvetkovic-Dozic D., Jovanvic V., Dozic S. Etiopathogenesis of multiple sclerosis. Arch Oncol 2001, 8-10.
48. Minguetti G. Magnetic resonance imaging in multiple sclerosis: analysis of 270 cases. Arq Neuropsiquiatr 2001, 59:563-569.
49. Saija A., Princi P., D'Amico N., De Pasquale R., Costa G. Effect of Vaccinium myrtillus anthocyanins on triiodothyronine transport into brain in the rat. Pharmacol Res 1990, 22(Suppl. 3):59-60.
50. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
51. Varadinova M.G., Docheva-Drenska D.I., Boyadjieva N.I. Effects of anthocyanins on learning and memory of ovariectomized rats. Menopause 2009, 16:345-349.
52. Cunha G.M., Canas P.M., Oliveira C.R., Cunha R.A. Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 2006, 141:1775-1781.
53. Canas P.M., Duarte J.M., Rodrigues R.J., Kofalvi A., Cunha R.A. Modification upon aging of the density of presynaptic modulation systems in the hippocampus. Neurobiol Aging 2009, 30:1877-1884.
54. Duarte J.M., Carvalho R.A., Cunha R.A., Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J Neurochem 2009, 111:368-379.
55. Kluver H., Barrera E. A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol 1953, 12:400-403.
56. Gutierres J.M., Carvalho F.B., Rosa M.M., Schmatz R., Rodrigues M.V., Vieira J.M., et al. Protective effect of α-tocopherol on memory deficits and Na+, K+-ATPase and acetylcholinesterase activities in rats with diet-induced hypercholesterolemia. Biomed Aging Pathol 2012, 2:73-80.
57. Wyse A.T., Streck E.L., Barros S.V., Brusque A.M., Zugno A.I., Wajner M. Methylmalonate administration decreases Na+, K+-ATPase activity in cerebral cortex of rats. Neuroreport 2000, 11:2331-2334.
58. Carvalho F.B., Mello C.F., Marisco P.C., Tonello R., Girardi B.A., Ferreira J., et al. Spermidine decreases Na(+), K(+)-ATPase activity through NMDA receptor and protein kinase G activation in the hippocampus of rats. Eur J Pharmacol 2012, 684:79-86.
59. Fiske C.H., Subbarow Y. The nature of the "inorganic phosphate" in voluntary muscle. Science 1927, 65:401-403.
60. Rohn T.T., Hinds T.R., Vincenzi F.F. Ion transport ATPases as targets for free radical damage. Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+ pump ATPase of human red blood cell membranes. Biochem Pharmacol 1993, 46:525-534.
61. Trevisan G., Maldaner G., Velloso N.A., Sant'Anna Gda S., Ilha V., Velho Gewehr Cde C., et al. Antinociceptive effects of 14-membered cyclopeptide alkaloids. J Nat Prod 2009, 72:608-612.
62. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972, 247:3170-3175.
63. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
64. Rossato J.I., Zeni G., Mello C.F., Rubin M.A., Rocha J.B. Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci Lett 2002, 318:137-140.
65. Miranda K.M., Espey M.G., Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5:62-71.
66. Yan L.J., Traber M.G., Packer L. Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. Anal Biochem 1995, 228:349-351.
67. Schneider Oliveira M., Flavia Furian A., Freire Royes L.F., Rechia Fighera M., de Carvalho Myskiw J., Gindri Fiorenza N., et al. Ascorbate modulates pentylenetetrazol-induced convulsions biphasically. Neuroscience 2004, 128:721-728.
68. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-478.
69. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
70. Lloret S., Moreno J.J. Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application. Biochem Pharmacol 1995, 50:347-353.
71. Suzuki M., Asano Y. Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium - N-acetyl-beta-d-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases. Rinsho Byori 1983, 139-146. [Spec No 56].
72. Silva M.A., Trevisan G., Klafke J.Z., Rossato M.F., Walker C.I., Oliveira S.M., et al. Antinociceptive and anti-inflammatory effects of Aloe saponaria Haw on thermal injury in rats. J Ethnopharmacol 2013, 146:393-401.
73. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
74. Woodruff R.H., Franklin R.J. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 1999, 25:216-228.
75. Smith K.J., Blakemore W.F., McDonald W.I. The restoration of conduction by central remyelination. Brain 1981, 104:383-404.
76. Aggarwal S., Yurlova L., Simons M. Central nervous system myelin: structure, synthesis and assembly. Trends Cell Biol 2011, 21:585-593.
77. Blakemore W.F., Franklin R.J. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol 2008, 318:193-212.
78. Blakemore W.F. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes. Neuropathol Appl Neurobiol 2005, 31:1-10.
79. Matsumoto H., Inaba H., Kishi M., Tominaga S., Hirayama M., Tsuda T. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem 2001, 49:1546-1551.
80. Miyazawa T., Nakagawa K., Kudo M., Muraishi K., Someya K. Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. J Agric Food Chem 1999, 47:1083-1091.
81. McGhie T.K., Ainge G.D., Barnett L.E., Cooney J.M., Jensen D.J. Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats. J Agric Food Chem 2003, 51:4539-4548.
82. Andres-Lacueva C., Shukitt-Hale B., Galli R.L., Jauregui O., Lamuela-Raventos R.M., Joseph J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 2005, 8:111-120.
83. Ghosh D., McGhie T.K., Zhang J., Adaim A., Skinner M. Effects of anthocyanins and other phenolics of boysenberry and blackcurrant as inhibitors of oxidative stress and damage to cellular DNA in SH-SY5Y and HL-60 cells. J Sci Food Agric 2006, 86:678-686.
84. Zhang Y., Vareed S.K., Nair M.G. Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life Sci 2005, 76:1465-1472.
85. Munoz-Espada A.C., Watkins B.A. Cyanidin attenuates PGE2 production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells. J Nutr Biochem 2006, 17:589-596.
86. Youdim K.A., Martin A., Joseph J.A. Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med 2000, 29:51-60.
87. Thomasset S., Berry D.P., Cai H., West K., Marczylo T.H., Marsden D., et al. Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res 2009, 2:625-633.
88. Thomasset S., Teller N., Cai H., Marko D., Berry D.P., Steward W.P., et al. Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs?. Cancer Chemother Pharmacol 2009, 64:201-211.
89. Cooke D.N., Thomasset S., Boocock D.J., Schwarz M., Winterhalter P., Steward W.P., et al. Development of analyses by high-performance liquid chromatography and liquid chromatography/tandem mass spectrometry of bilberry (Vaccinium myrtilus) anthocyanins in human plasma and urine. J Agric Food Chem 2006, 54:7009-7013.
90. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073S-2085S.
91. Frank J., Kamal-Eldin A., Lundh T., Maatta K., Torronen R., Vessby B. Effects of dietary anthocyanins on tocopherols and lipids in rats. J Agric Food Chem 2002, 50:7226-7230.
92. Gutierres J.M., Carvalho F.B., Schetinger M.R., Agostinho P., Marisco P.C., Vieira J.M., et al. Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats. Int J Dev Neurosci 2013, 33C:88-97.
93. Gutierres J.M., Carvalho F.B., Schetinger M.R., Marisco P., Agostinho P., Rodrigues M., et al. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type. Life Sci 2014, 96:7-17.
94. Vida C., Gonzalez E.M., Fuente M.D. Increase of oxidation and inflammation in nervous and immune systems with aging and anxiety. Curr Pharm Des 2014, 20:4656-4678.
95. Sutherland G.T., Chami B., Youssef P., Witting P.K. Oxidative stress in Alzheimer's disease: primary villain or physiological by-product?. Redox Rep 2013, 18:134-141.
96. Sultana R., Perluigi M., Allan Butterfield D. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med 2013, 62:157-169.
97. Abdel-Salam O.M., Khadrawy Y.A., Mohammed N.A., Youness E.R. The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain. J Basic Clin Physiol Pharmacol 2012, 23:61-68.
98. Abdel-Salam O.M., Khadrawy Y.A., Salem N.A., Sleem A.A. Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine. Neurochem Res 2011, 36:1062-1072.
99. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
100. Schmatz R., Perreira L.B., Stefanello N., Mazzanti C., Spanevello R., Gutierres J., et al. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 2012, 94:374-383.
101. Streck E.L., Zugno A.I., Tagliari B., Franzon R., Wannmacher C.M., Wajner M., et al. Inhibition of rat brain Na+, K+-ATPase activity induced by homocysteine is probably mediated by oxidative stress. Neurochem Res 2001, 26:1195-1200.
102. Franzon R., Lamers M.L., Stefanello F.M., Wannmacher C.M., Wajner M., Wyse A.T. Evidence that oxidative stress is involved in the inhibitory effect of proline on Na(+), K(+)-ATPase activity in synaptic plasma membrane of rat hippocampus. Int J Dev Neurosci 2003, 21:303-307.
103. Malfatti C.R., Burgos L.T., Rieger A., Rudger C.L., Turmina J.A., Pereira R.A., et al. Decreased erythrocyte NA+, K+-ATPase activity and increased plasma TBARS in prehypertensive patients. ScientificWorldJournal 2012, 2012:348-246.
104. Silva L.F., Hoffmann M.S., Rambo L.M., Ribeiro L.R., Lima F.D., Furian A.F., et al. The involvement of Na+, K+-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury. J Neurol Sci 2011, 308:35-40.
105. dos Reis E.A., de Oliveira L.S., Lamers M.L., Netto C.A., Wyse A.T. Arginine administration inhibits hippocampal Na(+), K(+)-ATPase activity and impairs retention of an inhibitory avoidance task in rats. Brain Res 2002, 951:151-157.
106. Wyse A.T., Bavaresco C.S., Bandinelli C., Streck E.L., Franzon R., Dutra-Filho C.S., et al. Nitric oxide synthase inhibition by l-NAME prevents the decrease of Na+, K+-ATPase activity in midbrain of rats subjected to arginine administration. Neurochem Res 2001, 26:515-520.
107. Oliveira M.S., Furian A.F., Rambo L.M., Ribeiro L.R., Royes L.F., Ferreira J., et al. Prostaglandin E2 modulates Na+, K+-ATPase activity in rat hippocampus: implications for neurological diseases. J Neurochem 2009, 109:416-426.
108. Bostock H., Sears T.A., Sherratt R.M. The spatial distribution of excitability and membrane current in normal and demyelinated mammalian nerve fibres. J Physiol 1983, 341:41-58.
109. Bostock H., Sears T.A. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol 1978, 280:273-301.
110. Waxman S.G., Craner M.J., Black J.A. Na+ channel expression along axons in multiple sclerosis and its models. Trends Pharmacol Sci 2004, 25:584-591.
111. Luo H., Lv X.D., Wang G.E., Li Y.F., Kurihara H., He R.R. Anti-inflammatory effects of anthocyanins-rich extract from bilberry (Vaccinium myrtillus L.) on croton oil-induced ear edema and Propionibacterium acnesplus LPS-induced liver damage in mice. Int J Food Sci Nutr 2014, 65:594-601.
112. Esposito D., Chen A., Grace M.H., Komarnytsky S., Lila M.A. Inhibitory effects of wild blueberry anthocyanins and other flavonoids on biomarkers of acute and chronic inflammation in vitro. J Agric Food Chem 2014, 62(29):7022-7028.
113. Lee S.G., Kim B., Yang Y., Pham T.X., Park Y.K., Manatou J., et al. Berry anthocyanins suppress the expression and secretion of proinflammatory mediators in macrophages by inhibiting nuclear translocation of NF-kappaB independent of NRF2-mediated mechanism. J Nutr Biochem 2013, 25(4):404-411.
114. Chen J.W., Breckwoldt M.O., Aikawa E., Chiang G., Weissleder R. Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 2008, 131:1123-1133.
115. Nagra R.M., Becher B., Tourtellotte W.W., Antel J.P., Gold D., Paladino T., et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997, 78:97-107.
116. Forghani R., Wojtkiewicz G.R., Zhang Y., Seeburg D., Bautz B.R., Pulli B., et al. Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. Radiology 2012, 263:451-460.
117. Wolf B.B., Green D.R. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 1999, 274:20049-20052.
118. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 2006, 354:942-955.
119. Rus H., Cudrici C., Niculescu F., Shin M.L. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection. J Neuroimmunol 2006, 180:9-16.
120. Rus H., Cudrici C., Niculescu F. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection. Adv Exp Med Biol 2006, 586:139-151.